Why the study?
Does Cystatin C predict the risk of death and cardiovascular events better than creatinine in elderly persons?
Does Cystatin C predict the risk of death and cardiovascular events better than creatinine in elderly persons?
Cystatin C is superior to creatinine as a prognostic marker for mortality and cardiovascular events in the elderly.
No takes yet. Share an insight, caveat, or question.
Cystatin C may enhance prognostication in elderly patients; leaves open whether it should supplant creatinine in clinical risk models.
Shlipak et al. (2005) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: